- 询价
- 辰辉创聚生物
- 中国
- NBAB-105196
- 2025年07月06日
- ELISA
- Human
企业认证
相关产品推荐更多 >
![ANO1 [TMEM16A]抗体 | Anti-ANO1 [TMEM16A] Monoclonal Antibody](https://img1.dxycdn.com/p/s14/2025/0915/531/8611176548562937691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human Coagulation Factor XI / F11 protein
- 亚型：
Monoclonal Rabbit IgG
- 保存条件：
This liquid antibody can be stored at 2℃-5078℃ for at least two weeks. Avoid repeated freeze/thaw cycles.
- 克隆性：
单克隆
- 适应物种：
Human
- 保质期：
see COA
- 库存：
大量
- 供应商：
辰辉创聚生物
- 应用范围：
ELISA
- 靶点：
Factor XI
- 抗体英文名：
Factor XI antibody
- 抗体名：
Factor XI抗体
- 规格：
100ug;500ug;1mg
| 产品信息
品名:NebuSelect™ Recombinant Anti-Factor XI Monoclonal Antibody
货号:NBAB-105196
品牌:Nebulabio
规格:100ug;500ug;1mg
| 产品描述
| 产品属性
Product Category：Rabbit MAb
Reactivity：Human
Specificity：Human Factor XI No cross-reactivity in ELISA with Human FX Human uPA Human KLK1 Human KLK11 Human HGFA Human KLK3 Human KLK4 Human KLK8
Immunogen：Recombinant Human Coagulation Factor XI / F11 protein
Isotype：Monoclonal Rabbit IgG
Purification：Protein A
Buffer：0.2 μm filtered solution in PBS
Conjugate：Unconjugated
Applications：ELISA
Dilution：ELISA: 1:5000-1:10000
Storage：Store at 4°C for short-term, -20°C for long-term. Avoid repeated freezing and thawing cycles.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Molecular Analysis in Factor XI Deficiency
Factor XI (FXI) is the zymogen precursor of an active serine protease that participates in the contact phase of coagulation. Synthesized in the liver, it circulates in the plasma in a noncovalent complex with high molecular weight kininogen
Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments
A growing number of recombinant antibodies is being developed for immunotherapy of cancer (1 ,2 ) (see also Chapter 2 ). Although these recombinant antibodies can exhibit a potent anti-tumoral activity in vitro, efficacy in vivo
Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma
Conventionally, monoclonal antibodies (MAbs) are generated by fusing B cells from an immunized animal with myeloma cells from the same species (1 ). Several murine MAb have already been employed for in vivo diagnosis and therapy, including
技术资料暂无技术资料 索取技术资料
